The Association of Nonalcoholic Fatty Liver Disease with Bone Mineral Density in Type 2 Diabetes

Overview

Journal Eur J Med Res

Publisher Biomed Central

Specialty General Medicine

Date 2022 Aug 7

PMID 35934712

Authors

Juan Du

Yan Ma

Hongmei Lang

Changquan Huang

Xingping Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: We examined the association between nonalcoholic fatty liver disease and lumbar spine bone mineral density in individuals with and without type 2 diabetes.

Methods: The lumbar BMD of 1088 subjects was measured using dual-energy X-ray absorptiometry (DXA). Liver fat content was quantified via B-mode ultrasound. Multivariable linear regression was used to study the association between NAFLD and lumbar BMD in participants with and without T2DM.

Results: The lumbar BMD in the T2DM group and the non-diabetes group was higher in the NAFLD group than in the non-NAFLD group (P < 0.001). Multivariate regression analysis in the T2DM group showed that after adjusting for confounders, the positive association between lumbar spine BMD and NAFLD remained (P = 0.027). In the non-diabetes group, after adjusting for confounders, the association between NAFLD and lumbar spine BMD disappeared.

Conclusions: The relationship between nonalcoholic fatty liver disease and lumbar bone mineral density may differ in individuals with and without diabetes. The effect of nonalcoholic fatty liver disease on bone mineral density needs to be evaluated in different clinical contexts.

Citing Articles

Nonlinear association between liver fat content and lumbar bone mineral density in overweight and obese individuals: evidence from a large-scale health screening data in China.

Liu A, Sun Y, Qi X, Zhou Y, Zhou J, Li Z Endocrine. 2025; .

PMID: 39869295 DOI: 10.1007/s12020-025-04168-0.

osteoclast differentiation enhanced by hepatocyte supernatants from high-fat diet mice.

Wang Y, Zhou F, Shu S, Wu Y, Tian H, Li Y Biochem Biophys Rep. 2024; 39:101788.

PMID: 39108622 PMC: 11301062. DOI: 10.1016/j.bbrep.2024.101788.

Optimal body mass index for protecting middle-aged and elderly patients with fatty liver from future fractures.

Yeh H, Wu H, Shen H, Li T, Yang Y, Lee K Endocr Connect. 2024; .

PMID: 38819306 PMC: 11227054. DOI: 10.1530/EC-24-0089.

References

Campos R, de Piano A, da Silva P, Carnier J, Sanches P, Corgosinho F . The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. Endocrine. 2012; 42(1):146-56. DOI: 10.1007/s12020-012-9613-3. View

Haukeland J, Dahl T, Yndestad A, Gladhaug I, Loberg E, Haaland T . Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol. 2011; 166(3):503-10. DOI: 10.1530/EJE-11-0864. View

Lebeaupin C, Vallee D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B . Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018; 69(4):927-947. DOI: 10.1016/j.jhep.2018.06.008. View

Cui Z, Xuan R, Yang Y . Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population. Oncotarget. 2018; 8(63):107149-107156. PMC: 5739803. DOI: 10.18632/oncotarget.22361. View

Sato M, Kamada Y, Takeda Y, Kida S, Ohara Y, Fujii H . Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects. Liver Int. 2015; 35(3):925-35. DOI: 10.1111/liv.12478. View

Lee S, Yun J, Kim S, Seo Y, Min H, Chung E . Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults. J Endocrinol Invest. 2016; 39(11):1329-1336. DOI: 10.1007/s40618-016-0528-3. View

Moon S, Lee Y, Kim S . Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine. 2012; 42(2):423-9. DOI: 10.1007/s12020-012-9639-6. View

Reid I . Effects of vitamin D supplements on bone density. J Endocrinol Invest. 2014; 38(1):91-4. DOI: 10.1007/s40618-014-0127-0. View

Lee S, Park S . Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol. 2014; 20(23):7392-402. PMC: 4064084. DOI: 10.3748/wjg.v20.i23.7392. View

10.

Chamberlain J, Herman W, Leal S, Rhinehart A, Shubrook J, Skolnik N . Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med. 2017; 166(8):572-578. DOI: 10.7326/M16-2937. View

11.

Compston J . Type 2 diabetes mellitus and bone. J Intern Med. 2017; 283(2):140-153. DOI: 10.1111/joim.12725. View

12.

Moyer-Mileur L, Slater H, Jordan K, Murray M . IGF-1 and IGF-binding proteins and bone mass, geometry, and strength: relation to metabolic control in adolescent girls with type 1 diabetes. J Bone Miner Res. 2008; 23(12):1884-91. PMC: 3276345. DOI: 10.1359/jbmr.080713. View

13.

Joy D, Thava V, Scott B . Diagnosis of fatty liver disease: is biopsy necessary?. Eur J Gastroenterol Hepatol. 2003; 15(5):539-43. DOI: 10.1097/01.meg.0000059112.41030.2e. View

14.

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

15.

Carracher A, Marathe P, Close K . International Diabetes Federation 2017. J Diabetes. 2018; 10(5):353-356. DOI: 10.1111/1753-0407.12644. View

16.

Ghodsi M, Larijani B, Keshtkar A, Nasli-Esfahani E, Alatab S, Mohajeri-Tehrani M . Mechanisms involved in altered bone metabolism in diabetes: a narrative review. J Diabetes Metab Disord. 2016; 15:52. PMC: 5111345. DOI: 10.1186/s40200-016-0275-1. View

17.

Cusi K . Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions. Diabetologia. 2016; 59(6):1112-20. PMC: 4861748. DOI: 10.1007/s00125-016-3952-1. View

18.

Targher G, Lonardo A, Rossini M . Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?. J Endocrinol Invest. 2015; 38(8):817-25. DOI: 10.1007/s40618-015-0315-6. View

19.

Muzica C, Sfarti C, Trifan A, Zenovia S, Cuciureanu T, Nastasa R . Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship. Can J Gastroenterol Hepatol. 2021; 2020:6638306. PMC: 7781697. DOI: 10.1155/2020/6638306. View

20.

Filip R, Radzki R, Bienko M . Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis. Clin Interv Aging. 2018; 13:1879-1891. PMC: 6174895. DOI: 10.2147/CIA.S170533. View